Dewan Sameer

Dewan Sameer (SVP) sold 15,088 shares of Genpact at $46.65, reducing holdings by -28.6% to 37.7K shares.

SVP Dewan Sameer sold 15,088 shares at $46.65, a substantial reduction of -28.6% of his pre-transaction holdings from 52.8K to 37.7K shares. The sale occurred at a price -16.2% below the 52-week high of $55.54, and at a level -0.3% below the current price of $46.52. Across his prior open-market trades at Genpact, his two prior sells (2025-11-11 and 2025-08-28) produced mixed timing outcomes: the August 2025 sale was followed by a 90-day decline of -1.8%, while the November 2025 sale shows a 30-day gain of +6.0% with the 90-day measurement not yet available. The magnitude of this reduction in holdings warrants attention, though the stock trades at a moderate P/E of 14.54 with recent 90-day performance of +18.0%.

Genpact SVP Sameer Dewan sold 26,531 shares at $44.70 on 2025-11-11, retaining 62,617 shares post-sale.

Sameer Dewan, Senior Vice President, executed an open-market sale of 26,531 shares (29.8% reduction in holdings) at $44.70, lowering his stake from 89,148 to 62,617 shares. The sale occurred in a context where Genpact's stock is currently -18.9% from its 52-week high of $55.54 but has gained 13.0% over the past 30 days and 3.2% over 90 days. Across his cross-ticker trading history, Dewan has executed 1 prior sell with an average 30-day return of -6.2%, and his single prior trade at G (a sell on 2025-08-28) also posted a 30-day return of -6.2%, though the 90-day outcome remains unmeasurable. Genpact's fundamentals remain intact with $1.3B in latest-quarter revenue, $145.8M net income, and a P/E of 14.08, providing limited fundamental context for the sale rationale.

SVP Dewan Sameer sold 20,078 shares of Genpact at $45.00; -18.4% from 52-week high.

Dewan Sameer, Senior Vice President of Genpact, sold 20,078 shares for $903,510.00, reducing his holdings by 18.4% from 109,226 to 89,148 shares. The sale occurred at $45.00 per share, approximately 18.4% below the 52-week high of $55.54. Genpact is a $7.9B market-cap company with solid fundamentals (6.5% annual revenue growth, P/E of 14.67, and latest quarter revenue of $1.3B). The stock has recovered 5.3% over the past 90 days and 2.6% over the past 30 days, suggesting recent price momentum. Without visibility into the executive's compensation structure, vesting schedules, or prior trading activity, the sale is most consistent with routine portfolio management by a senior executive retaining substantial ownership (89.1K shares post-transaction).